A

Alector

Biopharmaceutical R&D for neurodegenerative therapies

Senior Associate Scientist - Bioanalytical Sciences

Biology & BiotechUpdated on Nov 11
Full-timeSouth San Francisco, CA, USANo salary listed

About the Job

Requirements

  • A Bachelor of Science degree in Biology, Biochemistry, Pharmacology, Immunology, or a related scientific discipline with at least five years of relevant biotechnology or pharmaceutical industry experience, or a Master of Science degree in a related scientific discipline with at least three years of relevant industry experience.
  • Ability to independently develop pharmacokinetic, anti-drug antibody, and/or biomarker assays in biological samples including cerebrospinal fluid, serum/plasma, and tissue lysates, with hands-on assay design, development, optimization, troubleshooting, and qualification experience.
  • Direct bioanalytical experience supporting therapeutic modalities such as antibodies, bispecific antibodies, and/or conjugated small interfering RNA is required.
  • Strong hands-on experience with ligand-binding assay platforms such as enzyme-linked immunosorbent assay (ELISA) and Meso Scale Discovery (MSD), including evaluation of sensitivity, selectivity, precision, matrix effects, drug tolerance, and assay interference.
  • Experience authoring and reviewing bioanalytical method protocols, qualification and validation plans, standard operating procedures, data summaries, and technical reports.
  • Strong knowledge of Good Laboratory Practice (GLP) requirements and regulatory guidance from the U.S. Food and Drug Administration (FDA), International Council for Harmonisation (ICH), and European Medicines Agency (EMA) related to bioanalytical assay development, qualification, and validation.
  • Experience working with external contract research organizations (CROs) on assay transfer, validation, sample analysis, troubleshooting, and data review.
  • Strong experimental documentation and communication skills.
  • Active use of large language models and a strong interest in evolving artificial intelligence.

Responsibilities

  • Independently design, develop, optimize, troubleshoot, and qualify ligand-binding pharmacokinetic, anti-drug antibody, and biomarker assays across biological matrices including cerebrospinal fluid, serum/plasma, and tissue lysates.
  • Apply bioanalytical expertise to antibodies, bispecific antibodies, conjugated small interfering RNAs, and other emerging therapeutic approaches.
  • Plan and execute laboratory experiments using platforms such as ELISA and MSD, evaluate assay performance, investigate matrix effects and interference, and deliver reproducible, decision-ready data.
  • Coordinate assay transfer, validation, sample analysis, troubleshooting, data review, timelines, and study deliverables with CRO partners while maintaining scientific ownership and supporting work conducted in accordance with applicable GLP and regulatory expectations.
  • Integrate laboratory automation, artificial intelligence, and large language models to accelerate assay development, improve quality, and use resources more effectively.
  • Partner with colleagues across Research, Toxicology, Clinical Development, and other multidisciplinary teams; communicate experimental results, assay limitations, risks, and recommendations clearly.

Desired Qualifications

  • Experience developing neutralizing antibody assays or other immunogenicity assessments.
  • Experience supporting regulated bioanalytical method validation and sample analysis.
  • Experience with automated liquid- or sample-handling platforms such as Agilent Bravo, Hamilton, or Tecan.
  • Experience with Gyrolab and fit-for-purpose biomarker assay qualification.
  • Experience with Benchling, Watson LIMS, GraphPad Prism, SoftMax Pro, or comparable electronic laboratory and bioanalytical data systems.
  • Experience introducing new assay technologies, automation, or data-analysis approaches into laboratory workflows.

About the Company

Alector

Biopharmaceutical R&D for neurodegenerative therapies

Alector is a biopharmaceutical company that develops therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's. It uses insights from immunology, neurology, and human genetics to create medicines that help the body heal itself. The company focuses on researching and developing novel therapeutic candidates, mainly through early-stage clinical trials to quickly gather disease-specific data and improve the chances of success. Revenue and funding come from partnerships, grants, and eventual product commercialization. Alector aims to advance treatments for unmet medical needs in neurodegenerative diseases by pursuing a pipeline that combines scientific findings with strategic drug development.

Company size
51-200
Company stage
IPO
Headquarters
San Francisco, CA
Founded
2013

Recently Posted Jobs

Explore more opportunities at Alector

See more jobs